SlideShare a Scribd company logo
1 of 25
Download to read offline
HFOV     (high frequency oscillatory ventilation) is indicated for
ventilatory support and treatment of respiratory failure and
barotrauma.
The use of HFOV in the adult patient is an object of some debate
and as a rule is discouraged. It is recognized however, that
situations may arise where, short of ECMO, it is the only
modality left available to the practitioner.
Generally, it is felt that HFOV should not be used in patients with
a body weight over 50 kilograms. Weights above this will
generally require an amplitude pressure higher than the 3100A's
maximum output and lead to possible overheating, off-center
positioning, and potential failure of the piston.
Strategies in the use of HFOV in the larger patient are similar to
that used in the neonatal/pediatric population and are aimed at
maximizing oxygenation and adequate elimination of carbon
dioxide with the primary aim of incorporating lung protective
strategy.
OXYGENATION
Oxygenation will depend on the use of two parameters -
the FiO2 and the mean airway pressure (MAP). Initial MAP
settings should be established at between 5-10 cmH20
more than the mean on conventional ventilation and further
adjusted according to the SPO2 and x-ray findings revealing
atelectasis or hyperinflation.
It is recommended that MAP not be weaned until the
FiO2 is less than 60%.
Occasionally, when the patient is on a high FiO2 (>70%) the
MAP may have to be decreased to avoid hyperinflation
and/or barotrauma and a relative degree of hypoxemia and
hypercapnia may have to be accepted.
VENTILATION
The primary control for ventilation is the delta P or
amplitude pressure control.
Increasing the amplitude should result in greater volumes
and a decrease in PCO2.
If this is unsuccessful, lowering the frequency, i.e.
Hz/respiratory rate, can help. Remember 1Hz=60 BPM. In
the adult, rates between 5-8 Hz are acceptable. The
minimum frequency provided by the 3100A is 3 Hz.
A third method would be to increase the I-time from the
standard 33% up to a maximum of 50%. Even though
allowing for less expiratory time, increasing the I-time will
allow for the generation of a greater tidal volume. This may
also, paradoxically, reduce PO2.
It should be remembered that decreasing the frequency
is not a method of weaning as this, in fact, increases
ventilation.
Though somewhat debatable, and not as problematic as in
jet ventilators, there may be some difficulties with
humidification, leading to inspissated secretions. A
concomitant goal of medical therapy should be adequate
peripheral hydration.
While there are no positive contraindications to its use, side
effects may include hyper/hypoventilation, IVH, BPD,
necrotizing tracheal bronchitis, atelectasis, hypotension,
pneumothorax, pneumopericardium, pneumomediastinum,
pneumoperitoneum and PIE.
It is recommended that patients undergoing this therapy be
monitored with transcutaneous PO2 and PCO2 monitoring
as well as venous and arterial blood gasses when
necessary. Mechanical ventilation will be implemented,
maintained and adjusted by a Respiratory
Therapist. Decisions regarding changes in ventilation
therapy are a collaborative effort by the Respiratory
Therapist, Physician and Registered Nurse.
Specifications
Bias flow 0 - 40 lpm
Mean airway pressure 3 - 45 cmH20
Frequency 3 - 15 hz
% inspiratory time 30 - 50%
Power / Delta P 0 - 100 oscillator driver power
CALIBRATING PATENT CIRCUIT
1. Turn on source gas and set Bias Flow to 20 1pm
2. Set Mean Pressure Adjust and Mean Pressure Limit to
maximum (fully clockwise)
3. Push in and hold RESET while observing Mean
Pressure digital readout
4. Adjust Patient Circuit Calibration screw on right side of
control module to achieve a mean pressure between 39
and 43 cmH20.
5. Release reset button
VENTILATOR PERFORMANCE CHECK
1. Set frequency to 10 and % I-time to 33.
2. Set Bias Flow to 20 lpm
3. Depress RESET button long enough to allow MAP to
increase above 6 cmH20
4. With Mean Pressure Adjust control establish a mean
pressure of between 19 and 21 cmH20
5. Depress START/STOP button to cause oscillator to run
6. Increase POWER control setting to 6.0 and center
piston with Piston Centering control
7. With piston centered and a stable Delta P reading verify
that Delta P is between 56 and 75 and that MAP is between
17 and 23.
8. Depress START/STOP button to stop oscillator.
9. The 3100A is now ready for patient use.
THERAPEUTIC STRATEGIES
Ventilation is largely governed by changes in Delta P.
Increasing Delta P increases ventilation and vice versa. If
maximum Delta P will not provide sufficient ventilation, a
secondary strategy is to decrease the frequency. This takes
advantage of the fact that less Delta P is attenuated by ET
diameter at lower frequencies. If PCO2 is still elevated, % I-
time may be increased up to 50%.
Oxygenation is largely a function of MAP. Typically we
begin at a MAP 10% higher than that used in conventional
ventilation. Attempt to wean FiO2 to less than 70% before
weaning MAP
Managing Large Patients (>35 kg) on the 3100A Oscillator
What is the FDA's limit on patient weight for use of the 3100A?
While the pediatric prospective randomized controlled trial (RCT) was
limited to 35 kg, the FDA's Review Panel recognized that the range of
ventilation with the 3100A was more limited by physiologic
considerations rather than by absolute patient weight. As the MDDI
Gray Sheet reported in January 1995, "SensorMedics high frequency
ventilator approval for pediatric use should not limit indications to
patients who weigh less than 35 kilograms, FDA's Anesthesiology and
Respiratory Therapy Device Panel agreed at a Jan 20 meeting."
During the panel hearing for pediatric approval they noted that it
requires approximately 2 ml/kg to ventilate a patient with HFOV. With a
6 mm endotracheal tube, at maximum power and at a frequency of 3
Hz, approximately 180 ml could be delivered by the 3100A to a test
system with a compliance of 20 ml/cmH2O. This equates to a
theoretical 90 kg patient weight limit. As can be seen in Figure 1, a
larger endotracheal tube (9 mm) will enable even larger volumes to be
delivered, raising the theoretical weight limit.
Hfov  presentation (abdul fattah)
In summary, there is no upper weight limit for the 3100A.
No special forms, IRB approval or informed consent is
required for treating any child with an OI>13 with the
3100A.
What has been the largest patient managed with the
3100A?
While we are not aware of all large patients managed with
the 3100A, we do know of 2 patients weighing 110 and 113
kg (242 and 249 lb.) who were adequately ventilated with
the 3100A. We've started a database of large patients
(Table 1) and the mean weight of the survivors is 64.4 kg
(129 lb.)
Table 1. 3100A Large Patient Registry
When should I consider using the 3100A?
As with all candidates for the 3100A, the earlier, the better. When we went back
through the pediatric RCT data to answer this question, we found that waiting
more than 72 hours on CMV raised the odds ratio for chronic lung disease in
survivors to 25.2. In both the pediatric RCT and our adult 3100B pilot rescue
trial, waiting more than 10 days to initiate HFOV was statistically specific for
increased mortality.
The specific markers for use of the 3100A are:
Gross Air Leaks
ARDS or Intractable RSV Pneumonia
With increasing FIO2 requirements (>60%).
Use of PCIRV to recruit lung volume.
Use of paralysis for patient management.
Clinical experience in both pediatric and adult applications
has taught us that the ability of the 3100A to achieve
desired levels of PCO2 in larger patients is tied closely to
the prior amount of conventional ventilation. When larger
patients are selected early for this therapy, CO2 elimination
is more easily accomplished.
What are the recommended starting settings for use of
the 3100A in large patients?
FIO2 at 1.0
MAP starting 4-8 cmH2O above that on CMV.
Flowrate > 18 LPM, higher if required to meet MAP setting.
Frequency starting at 6 Hz.
Delta-P starting at a power setting of 4.0 and rapidly
increasing it to achieve adequate chest movement.
%I-Time set to 33%.
If CO2 retention persists at maximum settings, decreasing
the cuff pressure to allow gas to escape around the ET
tube will move the point of fresh gas supply from the wye
connector to the tip of the ET tube (Figure 2). This will
reduce the deadspace and lower PaCO2. Note: The bias
flow may have to be increased to compensate for the leak
and maintain MAP.
Hfov  presentation (abdul fattah)
What are the markers that the patient is failing on the
3100A?
Failure to oxygenate is defined by the inability to decrease
FIO2 by 10% within 24 hours. An OI < 42 at 24 hours of
HFOV is a good indicator of a positive response. An OI >42
at 48 hours has been specific for oxygenation failure and
non-survival.
Failure to improve or maintain adequate ventilation is
defined as the inability to maintain PaCO2 < 100 torr with a
pH > 7.25. It is extremely important to monitor PaCO2 in
larger patients.
As reported in the large patient registry, most patients who
survived had a significant oxygenation (OI) response within
the first few hours of HFOV.
3100A High Frequency Oscillatory Ventilation
Large Patient (>30 kg) Guideline Considerations and
Patient Management

Inclusion Criteria:
         OI > 13 (OI = 100 x FiO2 x Paw / PaO2) in two
arterial blood gases within a six hour period.
         Examples:
           A patient with a PaO2 of 60 torr on an FIO2 of
>.60 and a mean airway pressure > 13 cmH2O
           A patient with a PaO2 of 60 torr on an FIO2 of
>.40 and a mean airway pressure > 20 cmH2O *** If pH <
7.28 consider buffering the patient with THAM before
starting.
*** Assure adequate blood pressure
*** Special attention to ventilatory requirements and
PaCO2 should be emphasized in larger patients
Although patients with the following conditions have
been adequately managed with the 3100A,
consideration should be given to these factors prior to
institution of HFOV therapy:
        Patient diagnosed with increased Airway
Resistance.
        Elevated ICP
        Weight > 70 Kg
        Mean Arterial Pressure < 55 mm Hg
        Passive pulmonary blood flow dependency with
normal compliance
Clinical Experience with the 3100A Suggests that:
1.       There appears to be an inverse relationship
between prior days on CMV and ability to ventilate with the
3100A. As the limitation in size of patient is usually
constrained by ventilation requirements, the longer the time
on CMV prior to institution of HFOV, the smaller the patient
that may be able to be managed.
2.       Patients managed for more than 72 hours on CMV
for ARDS prior to transfer to HFOV have a more than 25
fold odds increase for developing chronic lung disease.
3.       Patients managed for more than 10 days on CMV
for ARDS prior to transfer to HFOV have a statistically
significant increased risk of mortality.
4.       Patients with an oxygenation index (OI) greater
than 42 after 48 hours of HFOV have a significantly
increased risk for non-survival and alternative therapeutic
options should be considered.
_______________________________________________
Information to obtain and patient preparation before
placing the patient on HFOV
1.        If patient has a PA catheter, measure and record
cardiac output, PCWP, SVO2
2.        CVP line -- CVP should be at least 8 mm Hg
3.        TcPCO2 monitor at 38-40 degrees C° to follow
trend information
4.       Arterial line for MAP monitoring and ABG analysis
Initial Set-Up
1.        Obtain HFOV Flowsheet
2.        Fill in conventional ventilator setting, blood gases,
medications, hemodynamics
3.        Just prior to instituting HFOV, suction patient well
and give one 10 second sustained recruitment inflation.
4.       All patients may require neuromuscular blockade
and sedation for initiation of HFOV.
Hfov  presentation (abdul fattah)
Hfov  presentation (abdul fattah)
Hfov  presentation (abdul fattah)
Hfov  presentation (abdul fattah)
Editor:
Abdul fattah Abro
Neonatal intensive care unit staff
Nurse
Karachi sindh

More Related Content

What's hot

Mvss part v weaning & liberation from mechanical ventilation
Mvss part v   weaning & liberation from mechanical ventilationMvss part v   weaning & liberation from mechanical ventilation
Mvss part v weaning & liberation from mechanical ventilationSanti Silairatana
 
:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent UpdatesGamal Agmy
 
Mechanical ventilation in obstructive airway diseases
Mechanical ventilation in obstructive airway diseasesMechanical ventilation in obstructive airway diseases
Mechanical ventilation in obstructive airway diseasesAnkur Gupta
 
PV Curve and Lung Recruitment
PV Curve and Lung RecruitmentPV Curve and Lung Recruitment
PV Curve and Lung RecruitmentDr.Mahmoud Abbas
 
Weaning from ventilator
Weaning from ventilatorWeaning from ventilator
Weaning from ventilatorRitoban C
 
Weaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqWeaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqtareq rahman
 
Weaning from mechanical ventilation
Weaning from mechanical ventilationWeaning from mechanical ventilation
Weaning from mechanical ventilationmauryaramgopal
 
Diagnosis and Assessment of copd
Diagnosis and Assessment of copdDiagnosis and Assessment of copd
Diagnosis and Assessment of copdAshraf ElAdawy
 
Ventilator Management In Different Disease Entities
Ventilator Management In Different Disease EntitiesVentilator Management In Different Disease Entities
Ventilator Management In Different Disease EntitiesDang Thanh Tuan
 
Determinants of weaning from mechanical ventilation
Determinants of weaning from mechanical ventilationDeterminants of weaning from mechanical ventilation
Determinants of weaning from mechanical ventilationJohnson Velukkaran
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway diseaseMuhammad Asim Rana
 
difficult weaning from Mechanical ventilator
 difficult weaning from Mechanical ventilator difficult weaning from Mechanical ventilator
difficult weaning from Mechanical ventilatorDr.Tarek Sabry
 
Ventilatory strategies in the icu
Ventilatory strategies in the icuVentilatory strategies in the icu
Ventilatory strategies in the icuNaresh Monigari
 
Weaning, extubation and decannulation
Weaning, extubation and decannulationWeaning, extubation and decannulation
Weaning, extubation and decannulationMostafa Elshazly
 
Weaning from mechanical ventilation 2019
Weaning from mechanical ventilation 2019Weaning from mechanical ventilation 2019
Weaning from mechanical ventilation 2019Mohamed Metwally
 

What's hot (20)

Mvss part v weaning & liberation from mechanical ventilation
Mvss part v   weaning & liberation from mechanical ventilationMvss part v   weaning & liberation from mechanical ventilation
Mvss part v weaning & liberation from mechanical ventilation
 
:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
Mechanical ventilation in obstructive airway diseases
Mechanical ventilation in obstructive airway diseasesMechanical ventilation in obstructive airway diseases
Mechanical ventilation in obstructive airway diseases
 
PV Curve and Lung Recruitment
PV Curve and Lung RecruitmentPV Curve and Lung Recruitment
PV Curve and Lung Recruitment
 
Weaning from ventilator
Weaning from ventilatorWeaning from ventilator
Weaning from ventilator
 
Weaning
WeaningWeaning
Weaning
 
Weaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqWeaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareq
 
Weaning from mechanical ventilation
Weaning from mechanical ventilationWeaning from mechanical ventilation
Weaning from mechanical ventilation
 
Diagnosis and Assessment of copd
Diagnosis and Assessment of copdDiagnosis and Assessment of copd
Diagnosis and Assessment of copd
 
Ventilator Management In Different Disease Entities
Ventilator Management In Different Disease EntitiesVentilator Management In Different Disease Entities
Ventilator Management In Different Disease Entities
 
Niv in emergency department ebm
Niv in emergency department ebmNiv in emergency department ebm
Niv in emergency department ebm
 
Determinants of weaning from mechanical ventilation
Determinants of weaning from mechanical ventilationDeterminants of weaning from mechanical ventilation
Determinants of weaning from mechanical ventilation
 
Icu management in obstructive airway disease
Icu management in obstructive airway diseaseIcu management in obstructive airway disease
Icu management in obstructive airway disease
 
mechanical ventilation weaning
mechanical ventilation weaningmechanical ventilation weaning
mechanical ventilation weaning
 
difficult weaning from Mechanical ventilator
 difficult weaning from Mechanical ventilator difficult weaning from Mechanical ventilator
difficult weaning from Mechanical ventilator
 
Niv and weaning
Niv and weaningNiv and weaning
Niv and weaning
 
Ventilatory strategies in the icu
Ventilatory strategies in the icuVentilatory strategies in the icu
Ventilatory strategies in the icu
 
Weaning, extubation and decannulation
Weaning, extubation and decannulationWeaning, extubation and decannulation
Weaning, extubation and decannulation
 
Weaning from mechanical ventilation 2019
Weaning from mechanical ventilation 2019Weaning from mechanical ventilation 2019
Weaning from mechanical ventilation 2019
 

Viewers also liked

Hfov in adult ards smith
Hfov in adult ards   smithHfov in adult ards   smith
Hfov in adult ards smithDang Thanh Tuan
 
02 บทที่ 2-เอกสารที่เกี่ยวข้อง
02 บทที่ 2-เอกสารที่เกี่ยวข้อง02 บทที่ 2-เอกสารที่เกี่ยวข้อง
02 บทที่ 2-เอกสารที่เกี่ยวข้องJariya Kommanee
 
Fallo acción popular 2009 0111
Fallo acción popular 2009 0111Fallo acción popular 2009 0111
Fallo acción popular 2009 0111Paonore
 
Presentatie elma multimedia 2208
Presentatie elma multimedia 2208Presentatie elma multimedia 2208
Presentatie elma multimedia 2208elmamultimedia
 
12 segd xlab_abigail_hartgray_slideshare
12 segd xlab_abigail_hartgray_slideshare12 segd xlab_abigail_hartgray_slideshare
12 segd xlab_abigail_hartgray_slideshareAbigail Gray
 
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -Hideki Akiba
 
Learning Commons Update 5/21/14
Learning Commons Update  5/21/14Learning Commons Update  5/21/14
Learning Commons Update 5/21/14Alida_Hanson
 
00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้Jariya Kommanee
 
Teaching principles
Teaching principlesTeaching principles
Teaching principlesAlida_Hanson
 
Presentatie elma multimedia 2208
Presentatie elma multimedia 2208Presentatie elma multimedia 2208
Presentatie elma multimedia 2208elmamultimedia
 
310174 แมตทีเรีย
310174 แมตทีเรีย310174 แมตทีเรีย
310174 แมตทีเรียChamp Cha
 
01 บทที่ 1-บทนำ แก้
01 บทที่ 1-บทนำ แก้01 บทที่ 1-บทนำ แก้
01 บทที่ 1-บทนำ แก้Jariya Kommanee
 
Lockhart art analys upload
Lockhart art analys uploadLockhart art analys upload
Lockhart art analys uploadbrucelockhart
 
งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB
 งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB
งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNBChamp Cha
 
Self hosted server applications - Adam Horvath
Self hosted server applications - Adam HorvathSelf hosted server applications - Adam Horvath
Self hosted server applications - Adam Horvathadamhorvath
 
310252 แมคคานิก
310252 แมคคานิก310252 แมคคานิก
310252 แมคคานิกChamp Cha
 
00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้Jariya Kommanee
 

Viewers also liked (20)

Hfov in adult ards smith
Hfov in adult ards   smithHfov in adult ards   smith
Hfov in adult ards smith
 
02 บทที่ 2-เอกสารที่เกี่ยวข้อง
02 บทที่ 2-เอกสารที่เกี่ยวข้อง02 บทที่ 2-เอกสารที่เกี่ยวข้อง
02 บทที่ 2-เอกสารที่เกี่ยวข้อง
 
Fallo acción popular 2009 0111
Fallo acción popular 2009 0111Fallo acción popular 2009 0111
Fallo acción popular 2009 0111
 
Presentatie elma multimedia 2208
Presentatie elma multimedia 2208Presentatie elma multimedia 2208
Presentatie elma multimedia 2208
 
12 segd xlab_abigail_hartgray_slideshare
12 segd xlab_abigail_hartgray_slideshare12 segd xlab_abigail_hartgray_slideshare
12 segd xlab_abigail_hartgray_slideshare
 
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -
Creative Cloud デザインツールの便利な8つの機能 - ADC MEETUP ROUND 08 SESSION2 -
 
Learning Commons Update 5/21/14
Learning Commons Update  5/21/14Learning Commons Update  5/21/14
Learning Commons Update 5/21/14
 
00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้
 
Creative lanna booklet(3)
Creative lanna booklet(3)Creative lanna booklet(3)
Creative lanna booklet(3)
 
Triptico
TripticoTriptico
Triptico
 
Teaching principles
Teaching principlesTeaching principles
Teaching principles
 
Presentatie elma multimedia 2208
Presentatie elma multimedia 2208Presentatie elma multimedia 2208
Presentatie elma multimedia 2208
 
Powerful presentation
Powerful presentationPowerful presentation
Powerful presentation
 
310174 แมตทีเรีย
310174 แมตทีเรีย310174 แมตทีเรีย
310174 แมตทีเรีย
 
01 บทที่ 1-บทนำ แก้
01 บทที่ 1-บทนำ แก้01 บทที่ 1-บทนำ แก้
01 บทที่ 1-บทนำ แก้
 
Lockhart art analys upload
Lockhart art analys uploadLockhart art analys upload
Lockhart art analys upload
 
งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB
 งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB
งานนำเสนอ ข้อมูลโรงเรียนบ้านโปร่ง esanNB
 
Self hosted server applications - Adam Horvath
Self hosted server applications - Adam HorvathSelf hosted server applications - Adam Horvath
Self hosted server applications - Adam Horvath
 
310252 แมคคานิก
310252 แมคคานิก310252 แมคคานิก
310252 แมคคานิก
 
00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้00 ส่วนนำ1 แก้
00 ส่วนนำ1 แก้
 

Similar to Hfov presentation (abdul fattah)

Sensormedics HIGH FREQUENCY VENTILATOR
Sensormedics HIGH FREQUENCY VENTILATORSensormedics HIGH FREQUENCY VENTILATOR
Sensormedics HIGH FREQUENCY VENTILATORalengleng28
 
Management of persistent hypoxemic respiratory failure in the icu garpestad
Management of persistent hypoxemic respiratory failure in the icu   garpestadManagement of persistent hypoxemic respiratory failure in the icu   garpestad
Management of persistent hypoxemic respiratory failure in the icu garpestadDang Thanh Tuan
 
High-Frequency Oscillatory Ventilation in Adult Patients
High-Frequency Oscillatory Ventilation in Adult PatientsHigh-Frequency Oscillatory Ventilation in Adult Patients
High-Frequency Oscillatory Ventilation in Adult PatientsSarahLindsey143
 
Modern Ventilator Management.pptx
Modern Ventilator Management.pptxModern Ventilator Management.pptx
Modern Ventilator Management.pptxMuhammadUmair677955
 
Modern Ventilator Management.pptx
Modern Ventilator Management.pptxModern Ventilator Management.pptx
Modern Ventilator Management.pptxMuhammadUmair677955
 
acute respiratory distress syndrome
acute respiratory distress syndromeacute respiratory distress syndrome
acute respiratory distress syndromeSoutrik SeTh
 
Ards refractory hypoxemia
Ards refractory hypoxemiaArds refractory hypoxemia
Ards refractory hypoxemiaMuhammad Badawi
 
Management of covid 19(ards)
Management of covid 19(ards)Management of covid 19(ards)
Management of covid 19(ards)Manish Khokhar
 
Covid 19 mechanical ventilation managment
Covid 19 mechanical  ventilation managmentCovid 19 mechanical  ventilation managment
Covid 19 mechanical ventilation managmentAnwar Yusr
 
Mechanical Ventilation in ARDS vs COPD
Mechanical Ventilation in ARDS vs COPDMechanical Ventilation in ARDS vs COPD
Mechanical Ventilation in ARDS vs COPDcairo1957
 
Acute respiratory distress syndrome carre
Acute respiratory distress syndrome   carreAcute respiratory distress syndrome   carre
Acute respiratory distress syndrome carreDang Thanh Tuan
 
High Frequency Oscillatory Ventilation
High Frequency Oscillatory VentilationHigh Frequency Oscillatory Ventilation
High Frequency Oscillatory Ventilationhappyneige
 
Weaning from mechanical ventilator
Weaning from mechanical ventilatorWeaning from mechanical ventilator
Weaning from mechanical ventilatorDr Subodh Chaturvedi
 

Similar to Hfov presentation (abdul fattah) (20)

Sensormedics HIGH FREQUENCY VENTILATOR
Sensormedics HIGH FREQUENCY VENTILATORSensormedics HIGH FREQUENCY VENTILATOR
Sensormedics HIGH FREQUENCY VENTILATOR
 
Management of persistent hypoxemic respiratory failure in the icu garpestad
Management of persistent hypoxemic respiratory failure in the icu   garpestadManagement of persistent hypoxemic respiratory failure in the icu   garpestad
Management of persistent hypoxemic respiratory failure in the icu garpestad
 
High-Frequency Oscillatory Ventilation in Adult Patients
High-Frequency Oscillatory Ventilation in Adult PatientsHigh-Frequency Oscillatory Ventilation in Adult Patients
High-Frequency Oscillatory Ventilation in Adult Patients
 
ASSISSTED VENTILATION.pdf
ASSISSTED VENTILATION.pdfASSISSTED VENTILATION.pdf
ASSISSTED VENTILATION.pdf
 
Ards m ibrahim
Ards m ibrahimArds m ibrahim
Ards m ibrahim
 
Care For Vent Pt
Care For Vent PtCare For Vent Pt
Care For Vent Pt
 
Hfov guidelines
Hfov guidelinesHfov guidelines
Hfov guidelines
 
ARDS
ARDSARDS
ARDS
 
Modern Ventilator Management.pptx
Modern Ventilator Management.pptxModern Ventilator Management.pptx
Modern Ventilator Management.pptx
 
Modern Ventilator Management.pptx
Modern Ventilator Management.pptxModern Ventilator Management.pptx
Modern Ventilator Management.pptx
 
acute respiratory distress syndrome
acute respiratory distress syndromeacute respiratory distress syndrome
acute respiratory distress syndrome
 
Ards refractory hypoxemia
Ards refractory hypoxemiaArds refractory hypoxemia
Ards refractory hypoxemia
 
Management of covid 19(ards)
Management of covid 19(ards)Management of covid 19(ards)
Management of covid 19(ards)
 
Covid 19 mechanical ventilation managment
Covid 19 mechanical  ventilation managmentCovid 19 mechanical  ventilation managment
Covid 19 mechanical ventilation managment
 
Mechanical Ventilation in ARDS vs COPD
Mechanical Ventilation in ARDS vs COPDMechanical Ventilation in ARDS vs COPD
Mechanical Ventilation in ARDS vs COPD
 
Ventilation in ARDS
Ventilation in ARDSVentilation in ARDS
Ventilation in ARDS
 
Acute respiratory distress syndrome carre
Acute respiratory distress syndrome   carreAcute respiratory distress syndrome   carre
Acute respiratory distress syndrome carre
 
Covid pneumonia
Covid pneumoniaCovid pneumonia
Covid pneumonia
 
High Frequency Oscillatory Ventilation
High Frequency Oscillatory VentilationHigh Frequency Oscillatory Ventilation
High Frequency Oscillatory Ventilation
 
Weaning from mechanical ventilator
Weaning from mechanical ventilatorWeaning from mechanical ventilator
Weaning from mechanical ventilator
 

More from Abdul Fatah Abro

More from Abdul Fatah Abro (6)

Neonatal assisted ventilation
Neonatal assisted ventilation   Neonatal assisted ventilation
Neonatal assisted ventilation
 
Volutrauma presentation Abdul fatah
Volutrauma presentation Abdul fatahVolutrauma presentation Abdul fatah
Volutrauma presentation Abdul fatah
 
Picc line by abdul fatah
Picc line by abdul fatahPicc line by abdul fatah
Picc line by abdul fatah
 
PGE tube
PGE tube PGE tube
PGE tube
 
Respiratory acidosis
Respiratory acidosisRespiratory acidosis
Respiratory acidosis
 
Neonatal physiology
Neonatal  physiologyNeonatal  physiology
Neonatal physiology
 

Recently uploaded

Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...raviapr7
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxDr. Santhosh Kumar. N
 

Recently uploaded (20)

Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptx
 

Hfov presentation (abdul fattah)

  • 1. HFOV (high frequency oscillatory ventilation) is indicated for ventilatory support and treatment of respiratory failure and barotrauma. The use of HFOV in the adult patient is an object of some debate and as a rule is discouraged. It is recognized however, that situations may arise where, short of ECMO, it is the only modality left available to the practitioner. Generally, it is felt that HFOV should not be used in patients with a body weight over 50 kilograms. Weights above this will generally require an amplitude pressure higher than the 3100A's maximum output and lead to possible overheating, off-center positioning, and potential failure of the piston. Strategies in the use of HFOV in the larger patient are similar to that used in the neonatal/pediatric population and are aimed at maximizing oxygenation and adequate elimination of carbon dioxide with the primary aim of incorporating lung protective strategy.
  • 2. OXYGENATION Oxygenation will depend on the use of two parameters - the FiO2 and the mean airway pressure (MAP). Initial MAP settings should be established at between 5-10 cmH20 more than the mean on conventional ventilation and further adjusted according to the SPO2 and x-ray findings revealing atelectasis or hyperinflation. It is recommended that MAP not be weaned until the FiO2 is less than 60%. Occasionally, when the patient is on a high FiO2 (>70%) the MAP may have to be decreased to avoid hyperinflation and/or barotrauma and a relative degree of hypoxemia and hypercapnia may have to be accepted.
  • 3. VENTILATION The primary control for ventilation is the delta P or amplitude pressure control. Increasing the amplitude should result in greater volumes and a decrease in PCO2. If this is unsuccessful, lowering the frequency, i.e. Hz/respiratory rate, can help. Remember 1Hz=60 BPM. In the adult, rates between 5-8 Hz are acceptable. The minimum frequency provided by the 3100A is 3 Hz. A third method would be to increase the I-time from the standard 33% up to a maximum of 50%. Even though allowing for less expiratory time, increasing the I-time will allow for the generation of a greater tidal volume. This may also, paradoxically, reduce PO2. It should be remembered that decreasing the frequency is not a method of weaning as this, in fact, increases ventilation.
  • 4. Though somewhat debatable, and not as problematic as in jet ventilators, there may be some difficulties with humidification, leading to inspissated secretions. A concomitant goal of medical therapy should be adequate peripheral hydration. While there are no positive contraindications to its use, side effects may include hyper/hypoventilation, IVH, BPD, necrotizing tracheal bronchitis, atelectasis, hypotension, pneumothorax, pneumopericardium, pneumomediastinum, pneumoperitoneum and PIE.
  • 5. It is recommended that patients undergoing this therapy be monitored with transcutaneous PO2 and PCO2 monitoring as well as venous and arterial blood gasses when necessary. Mechanical ventilation will be implemented, maintained and adjusted by a Respiratory Therapist. Decisions regarding changes in ventilation therapy are a collaborative effort by the Respiratory Therapist, Physician and Registered Nurse. Specifications Bias flow 0 - 40 lpm Mean airway pressure 3 - 45 cmH20 Frequency 3 - 15 hz % inspiratory time 30 - 50% Power / Delta P 0 - 100 oscillator driver power
  • 6. CALIBRATING PATENT CIRCUIT 1. Turn on source gas and set Bias Flow to 20 1pm 2. Set Mean Pressure Adjust and Mean Pressure Limit to maximum (fully clockwise) 3. Push in and hold RESET while observing Mean Pressure digital readout 4. Adjust Patient Circuit Calibration screw on right side of control module to achieve a mean pressure between 39 and 43 cmH20. 5. Release reset button
  • 7. VENTILATOR PERFORMANCE CHECK 1. Set frequency to 10 and % I-time to 33. 2. Set Bias Flow to 20 lpm 3. Depress RESET button long enough to allow MAP to increase above 6 cmH20 4. With Mean Pressure Adjust control establish a mean pressure of between 19 and 21 cmH20 5. Depress START/STOP button to cause oscillator to run 6. Increase POWER control setting to 6.0 and center piston with Piston Centering control 7. With piston centered and a stable Delta P reading verify that Delta P is between 56 and 75 and that MAP is between 17 and 23. 8. Depress START/STOP button to stop oscillator. 9. The 3100A is now ready for patient use.
  • 8. THERAPEUTIC STRATEGIES Ventilation is largely governed by changes in Delta P. Increasing Delta P increases ventilation and vice versa. If maximum Delta P will not provide sufficient ventilation, a secondary strategy is to decrease the frequency. This takes advantage of the fact that less Delta P is attenuated by ET diameter at lower frequencies. If PCO2 is still elevated, % I- time may be increased up to 50%. Oxygenation is largely a function of MAP. Typically we begin at a MAP 10% higher than that used in conventional ventilation. Attempt to wean FiO2 to less than 70% before weaning MAP
  • 9. Managing Large Patients (>35 kg) on the 3100A Oscillator What is the FDA's limit on patient weight for use of the 3100A? While the pediatric prospective randomized controlled trial (RCT) was limited to 35 kg, the FDA's Review Panel recognized that the range of ventilation with the 3100A was more limited by physiologic considerations rather than by absolute patient weight. As the MDDI Gray Sheet reported in January 1995, "SensorMedics high frequency ventilator approval for pediatric use should not limit indications to patients who weigh less than 35 kilograms, FDA's Anesthesiology and Respiratory Therapy Device Panel agreed at a Jan 20 meeting." During the panel hearing for pediatric approval they noted that it requires approximately 2 ml/kg to ventilate a patient with HFOV. With a 6 mm endotracheal tube, at maximum power and at a frequency of 3 Hz, approximately 180 ml could be delivered by the 3100A to a test system with a compliance of 20 ml/cmH2O. This equates to a theoretical 90 kg patient weight limit. As can be seen in Figure 1, a larger endotracheal tube (9 mm) will enable even larger volumes to be delivered, raising the theoretical weight limit.
  • 11. In summary, there is no upper weight limit for the 3100A. No special forms, IRB approval or informed consent is required for treating any child with an OI>13 with the 3100A. What has been the largest patient managed with the 3100A? While we are not aware of all large patients managed with the 3100A, we do know of 2 patients weighing 110 and 113 kg (242 and 249 lb.) who were adequately ventilated with the 3100A. We've started a database of large patients (Table 1) and the mean weight of the survivors is 64.4 kg (129 lb.) Table 1. 3100A Large Patient Registry
  • 12. When should I consider using the 3100A? As with all candidates for the 3100A, the earlier, the better. When we went back through the pediatric RCT data to answer this question, we found that waiting more than 72 hours on CMV raised the odds ratio for chronic lung disease in survivors to 25.2. In both the pediatric RCT and our adult 3100B pilot rescue trial, waiting more than 10 days to initiate HFOV was statistically specific for increased mortality. The specific markers for use of the 3100A are: Gross Air Leaks ARDS or Intractable RSV Pneumonia With increasing FIO2 requirements (>60%). Use of PCIRV to recruit lung volume. Use of paralysis for patient management.
  • 13. Clinical experience in both pediatric and adult applications has taught us that the ability of the 3100A to achieve desired levels of PCO2 in larger patients is tied closely to the prior amount of conventional ventilation. When larger patients are selected early for this therapy, CO2 elimination is more easily accomplished. What are the recommended starting settings for use of the 3100A in large patients? FIO2 at 1.0 MAP starting 4-8 cmH2O above that on CMV. Flowrate > 18 LPM, higher if required to meet MAP setting. Frequency starting at 6 Hz. Delta-P starting at a power setting of 4.0 and rapidly increasing it to achieve adequate chest movement. %I-Time set to 33%.
  • 14. If CO2 retention persists at maximum settings, decreasing the cuff pressure to allow gas to escape around the ET tube will move the point of fresh gas supply from the wye connector to the tip of the ET tube (Figure 2). This will reduce the deadspace and lower PaCO2. Note: The bias flow may have to be increased to compensate for the leak and maintain MAP.
  • 16. What are the markers that the patient is failing on the 3100A? Failure to oxygenate is defined by the inability to decrease FIO2 by 10% within 24 hours. An OI < 42 at 24 hours of HFOV is a good indicator of a positive response. An OI >42 at 48 hours has been specific for oxygenation failure and non-survival. Failure to improve or maintain adequate ventilation is defined as the inability to maintain PaCO2 < 100 torr with a pH > 7.25. It is extremely important to monitor PaCO2 in larger patients. As reported in the large patient registry, most patients who survived had a significant oxygenation (OI) response within the first few hours of HFOV.
  • 17. 3100A High Frequency Oscillatory Ventilation Large Patient (>30 kg) Guideline Considerations and Patient Management Inclusion Criteria: OI > 13 (OI = 100 x FiO2 x Paw / PaO2) in two arterial blood gases within a six hour period. Examples: A patient with a PaO2 of 60 torr on an FIO2 of >.60 and a mean airway pressure > 13 cmH2O A patient with a PaO2 of 60 torr on an FIO2 of >.40 and a mean airway pressure > 20 cmH2O *** If pH < 7.28 consider buffering the patient with THAM before starting. *** Assure adequate blood pressure *** Special attention to ventilatory requirements and PaCO2 should be emphasized in larger patients
  • 18. Although patients with the following conditions have been adequately managed with the 3100A, consideration should be given to these factors prior to institution of HFOV therapy: Patient diagnosed with increased Airway Resistance. Elevated ICP Weight > 70 Kg Mean Arterial Pressure < 55 mm Hg Passive pulmonary blood flow dependency with normal compliance
  • 19. Clinical Experience with the 3100A Suggests that: 1. There appears to be an inverse relationship between prior days on CMV and ability to ventilate with the 3100A. As the limitation in size of patient is usually constrained by ventilation requirements, the longer the time on CMV prior to institution of HFOV, the smaller the patient that may be able to be managed. 2. Patients managed for more than 72 hours on CMV for ARDS prior to transfer to HFOV have a more than 25 fold odds increase for developing chronic lung disease. 3. Patients managed for more than 10 days on CMV for ARDS prior to transfer to HFOV have a statistically significant increased risk of mortality. 4. Patients with an oxygenation index (OI) greater than 42 after 48 hours of HFOV have a significantly increased risk for non-survival and alternative therapeutic options should be considered. _______________________________________________
  • 20. Information to obtain and patient preparation before placing the patient on HFOV 1. If patient has a PA catheter, measure and record cardiac output, PCWP, SVO2 2. CVP line -- CVP should be at least 8 mm Hg 3. TcPCO2 monitor at 38-40 degrees C° to follow trend information 4. Arterial line for MAP monitoring and ABG analysis Initial Set-Up 1. Obtain HFOV Flowsheet 2. Fill in conventional ventilator setting, blood gases, medications, hemodynamics 3. Just prior to instituting HFOV, suction patient well and give one 10 second sustained recruitment inflation. 4. All patients may require neuromuscular blockade and sedation for initiation of HFOV.
  • 25. Editor: Abdul fattah Abro Neonatal intensive care unit staff Nurse Karachi sindh